key: cord-0808262-9t7lnoio authors: Pusterla, N.; Gebhart, C. title: Equine proliferative enteropathy caused by Lawsonia intracellularis date: 2010-01-05 journal: Equine Vet Educ DOI: 10.2746/095777309x453119 sha: 91b664b40e295047dc06aa694341ba40272108ba doc_id: 808262 cord_uid: 9t7lnoio Equine proliferative enteropathy (EPE) is a disease of foals caused by the obligate intracellular organism Lawsonia intracellularis. This emerging disease affects mainly weanling foals and causes fever, lethargy, peripheral oedema, diarrhoea, colic and weight loss. The diagnosis of EPE may be challenging and relies on the presence of hypoproteinaemia, thickening of segments of the small intestinal wall observed on abdominal ultrasonography, positive serology and molecular detection of L. intracellularis in faeces. Although the clinical entity, diagnostic work‐up and treatment of EPE are well established and described, the epidemiology for this disease has remained largely unaddressed. This article reviews the aetiology, epidemiology, clinical signs, diagnosis, treatment and prevention of EPE. The accompanying report by Allen et al. (2009) describes an unusual case of Lawsonia intracellularis proliferative enteropathy (PE) with concurrent lymphocytic, plasmacytic enteritis. Although the correlation between the 2 enteropathies has not been established, this report illustrates an increasing awareness of a recently described disorder in foals. Lawsonia intracellularis is the aetiological agent of the recently recognised and emerging intestinal disease in horses, called equine PE (EPE) (Lavoie et al. 2000) . L. intracellularis is an obligate intracellular, curved, Gramnegative bacterium that resides freely within the apical cytoplasm of infected intestinal enterocytes. It causes proliferation of the affected enterocytes, resulting in a thickened small and sometimes large intestine. L. intracellularis can only be grown in vitro in cell culture and requires a specific atmosphere for growth. Besides horses, L. intracellularis infects many species of domestic and wild animals, including pigs, hamsters, rabbits, fox, deer, ferrets, ostriches and nonhuman primates. EPE was first reported in horses in 1982 by Duhamel and Wheeldon (1982) . Since 1996, many more reports of sporadic cases (Williams et al. 1996; Frank et al. 1998; Brees et al. 1999; Schumacher et al. 2000; Bihr 2003; McClintock and Collins 2004; Deprez et al. 2005; Dauvillier et al. 2006; Sampieri et al. 2006; Wuersch et al. 2006; Feary et al. 2007 ) and outbreaks on breeding farms (Lavoie et al. 2000; McGurrin et al. 2007; Frazer 2008; Merlo et al. 2009 ) have been described. In the last few years, reported cases of EPE have been increasing, primarily in post weaning foals and occasionally in adult horses. The disease has almost reached a worldwide distribution and has been reported in the USA, Canada, Europe, South Africa and Australia. Molecular investigations of L. intracellularis isolates from PE lesions of a variety of animal species, including horses and hamsters, showed 98% homology of the 16S-rDNA gene to pig isolates (Cooper and Gebhart 1998) . Moreover, phenotypic characterisation of outer membrane proteins and immunoblots of different L. intracellularis isolates using several antibodies and more sensitive molecular characterisations of the L. intracellularis genome demonstrated only minor differences among isolates. None of these differences appears to be antigenically relevant. A preliminary investigation into the epidemiological relationships between L. intracellularis isolates from pigs and horses suggests that they represent different strains and therefore may be species specific (Al-Ghamdi 2003) . disease. Predisposing factors such as the stress of weaning and parasitism have been suggested in the development of PE in foals. The route of infection for weanling foals remains unknown, however, in comparison to other species, a faeco-oral route is suspected, via contaminated feed and/or water. In pigs, the incubation period is 2-3 weeks following exposure; however, this period has not been determined for horses. Because of the wide host range of PE, numerous potential reservoir hosts exist. Lawsonia intracellularis has recently been detected by PCR from the faeces of a variety of domestic and wild animals (Herbst et al. 2003; Tomanová et al. 2003; Pusterla et al. 2008a) . Despite an ever-increasing range of host species, L. intracellularis is currently not to be considered a zoonotic disease. The role of clinically and subclinically infected horses in the transmission of L. intracellularis needs further investigation. Epidemiological investigations on premises from which clinical cases have been identified have revealed that 10-65% of unaffected foals and adult horses test seropositive for L. intracellularis (Frazer 2008; Pusterla et al. 2008b Pusterla et al. , 2009a . There are characteristic signalment, seasonality, clinical signs and blood work abnormalities associated with EPE. The disease is generally manifested in foals aged 2-8 months and in North America is often seen between August and January (Frazer 2008) . Lethargy, anorexia, fever, peripheral oedema (ventrum, sheath, throatlatch and distal limbs; Figs 1 and 2), weight loss (Fig 3) colic and diarrhoea (Fig 4) are amongst the most common clinical findings in affected foals. Although diarrhoea is commonly seen in affected foals and can vary from 'cow pat' to watery, some affected foals may have normal faecal character. Foals with EPE may also have concurrent disorders such as respiratory tract infections, gastric ulcerations and intestinal parasitism. One must keep in mind that signs of EPE may resemble those of more common gastrointestinal disorders such as parasitism, bacterial infections (Clostridium spp., Salmonella spp., Rhodococcus equi), rotavirus, coronavirus, ulcerations, sand accumulation and intestinal obstruction. Similar to pigs, the disease is often subclinical in foals; however, it will remain to be determined if growth retardation or unthriftiness is associated with subclinical infection. The ante mortem diagnosis of EPE may be challenging and relies on the presence of hypoproteinaemia, exclusion of common enteric diseases, thickening of segments of the small intestinal wall observed on abdominal ultrasonography, positive serology and molecular detection of L. intracellularis in faeces. The most consistent laboratory finding is hypoproteinaemia due to hypoalbuminaemia. Total Fig 1: Ventral and distal limb oedema in a 7 -month-old Thoroughbred filly with proliferative enteropathy. protein concentration is generally less than 50 g/l and albumin is usually <20 g/l. In a recent case report by Frazer (2008) , hypoalbuminaemia was the only consistent clinicopathological abnormality of 57 affected foals with albumin concentrations ranging from 9-33 g/l (normal reference range 31-41 g/l). Affected foals may also demonstrate nonspecific blood abnormalities such as anaemia or haemoconcentration, leucocytosis or neutropenia, hyperfibrinogenaemia, increased activity of muscle enzymes and electrolyte abnormalities (hypocalcaemia, hypochloraemia and hyponatraemia). Abdominal ultrasonography, although not very sensitive, may show segments of thickened small intestine (Fig 5) and excessive abdominal fluid. In these cases, abdominocentesis will yield a noninflammatory transudate. Culture of L. intracellularis from faeces is not practical due to its obligate intracellular nature. Several PCR assays have been developed for the detection of L. intracellularis in faeces. The sensitivity and specificity of the PCR technique in faecal samples has been evaluated for pigs and showed variable sensitivity and consistently high specificity (Guedes et al. 2002; Jacobson et al. 2004) . Sensitivity is affected by sample quality and the presence of inhibitory factors in faeces. PCR appears to reliably demonstrate L. intracellularis in the faeces of clinically affected horses early in the course of the disease but often fails to detect the organism in the faeces of subclinically infected animals, animals with prolonged course of disease or foals treated with antimicrobials prior to faecal analysis. Animals exposed to L. intracellularis develop serum IgG antibodies specific for the organism. Current methods used for serological diagnosis of PE employ L. intracellularis cultured in enterocytes or a preparation of L. intracellularis on slides as the antigen. Staining of bacteria is either by a fluorescent (indirect fluorescent antibody) or peroxidaselabelled (immunoperoxidase monolayer assay) secondary antibody. One must keep in mind that a positive serological result may represent exposure to infection rather than disease. Although no commercially available serological assay has yet been systemically evaluated for the equine species, serological assays have proven useful N. Pusterla and C. Gebhart 417 for routine diagnosis of PE in horses, when combined with clinical signs and molecular detection of L. intracellularis in the faeces. Lesions are most commonly seen in the ileum, near the ileo-caecal junction, and appear as a thickening of the mucosa (Fig 6) . Gross lesions are not evident in all cases of EPE and may often be overlooked. Severe PE is diagnosed by the demonstration of hyperplasia of the crypt glands with an increased number of mitotic figures and absence of goblet cells in routine haematoxylin and eosin preparations; however, for visualisation of the bacteria in the cytoplasm of enterocytes, special stains are necessary. The histological lesions of PE are unique and inflammation is not normally a hallmark of the disease. Warthin-Starry silver stain allows the detection of the bacteria in histological sections, improving the diagnostic sensitivity, but the technique has limitations when applied to autolysed and necrotic samples. Immunohistochemistry procedures, using post mortem tissue or biopsy material, with an antibody specific for L. intracellularis have been used successfully to diagnosis EPE (Fig 7) . It is important to treat affected animals early, before lesions become advanced resulting in marked weight loss and critically low serum protein values. Treatment of EPE in horses involves the use of antimicrobials such as macrolides alone or in combination with rifampin, chloramphenicol, oxytetracycline or doxycycline administered for 3 weeks. The choice of antimicrobial in the treatment of EPE should take into account the risk of inducing disturbance of the gastrointestinal flora and renal toxicity. This is especially a concern when treating older foals with severe hypoalbuminaemia. In addition, supportive care such as i.v. fluids, plasma transfusion, parenteral nutrition and antiulcer drugs are commonly used to treat affected foals. Concurrent medical conditions should also be addressed. Rapid clinical improvement following treatment is to be expected, although it may take weeks for the hypoproteinaemia to resolve. Spontaneous recovery of clinically affected foals has not been documented and treated foals usually survive the disease. Long-term sequelae have not been reported; however, clinically affected and successfully treated foals sell for an average of 68% less than the average price of unaffected foals by the same stallion (Frazer 2008) . Prevention strategies have been best described in pigs using in-feed antimicrobials and a commercially available L. intracellularis vaccine (Lawson and Gebhart 2000; Kroll et al. 2004; McOrist and Smits 2007) . Recent work has shown that detectable humoral response can be measured in foals administered an avirulent live L. intracellularis vaccine (Pusterla et al. 2009b ). However, the efficacy and protection conferred by this strategy needs to be further investigated via field efficacy trials and experimental challenge studies. Equine proliferative enteropathy is an emerging disease in horses caused by L. intracellularis, an obligate intracellular bacterium. Increased awareness of this disease in the field and the availability of diagnostics for detecting the organism in horses have resulted in increased reports of the disease worldwide. The epidemiology and pathogenesis of L. intracellularis infection in horses are now being actively investigated. Characterization of Proliferative Enteropathy in Horses Lawsonia intracellularis proliferative enteropathy in a weanling foal, with a tentative histological diagnosis of lymphocytic plasmacytic enteritis. Equine vet Protein-losing enteropathy caused by Lawsonia intracellularis in a weanling foal Lawsonia intracellularis-like organism infection in a miniature foal Comparative aspects of proliferative enteritis Diagnostic and epidemiological features of Lawsonia intracellularis enteropathy in 2 foals Lawsonia intracellularis infection in a 12-month-old colt in Belgium Intestinal adenomatosis in a foal Lawsonia intracellularis proliferative enteropathy in a foal Lawsonia intracellularis proliferative enteropathy in a weanling foal Lawsonia intracellularis infection in horses Comparison of different methods for diagnosis of porcine proliferative enteropathy Diagnosis of Lawsonia intracellularis using the polymerase chain reaction (PCR) in pigs with and without diarrhea and other animal species Routine diagnostics of Lawsonia intracellularis performed by PCR, serological and post mortem examination, with special emphasis on sample preparation methods for PCR Evaluation of protective immunity in pigs following oral administration of an avirulent live vaccine of Lawsonia intracellularis Equine proliferative enteropathy: a cause of weight loss, colic, diarrhoea and hypoproteinemia in foals on three breeding farms in Canada Proliferative enteropathy Lawsonia intracellularis proliferative enteropathy in a weanling foal in Australia An outbreak of Lawsonia intracellularis infection in a standardbred herd in Ontario Field evaluation of an oral attenuated Lawsonia intracellularis vaccine for porcine proliferative enteropathy (ileitis) Outbreak of Lawsonia intracellularis on a Standardbred farm in North Carolina Detection of Lawsonia intracellularis by real-time PCR in the feces of free-living animals from equine farms with documented occurrence of equine proliferative enteropathy Epidemiological survey on farms with documented occurrence of equine proliferative enteropathy due to Lawsonia intracellularis Temporal detection of Lawsonia intracellularis using serology and real-time PCR in Thoroughbred horses residing on a farm endemic for equine proliferative enteropathy Evaluation of the humoral immune response and fecal shedding in weanling foals following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia intracellularis Tetracycline therapy of Lawsonia intracellularis enteropathy in foals Surgical and medical treatment of an Arabian filly with proliferative enteropathy caused by Lawsonia intracellularis Lawsonia intracellularis in wild mammals in the Slovak Carpathians Proliferative enteropathy in a foal caused by Lawsonia intracellularis-like bacterium Lawsonia intracellularis proliferative enteropathy in a filly